SlideShare ist ein Scribd-Unternehmen logo
1 von 45
Downloaden Sie, um offline zu lesen
M E N I N G I T I S
P R E S E N T E D B Y
N U R U L H I D A Y U B I N T I I B R A H I M
N I K N O R L I Y A N A
OUTLINE
1. Introduction to meningitis
2. Risk factor
3. Anatomy and prognosis
4. Aetiology
5. History and physical examination
6. Clinical features
7. Complications
8. Differential diagnosis
9. Investigations
10. Management
INTRODUCTION
 Meningitis is a disease caused by the inflammation of the meninges.
 The inflammation is usually caused by an infection of the fluid surrounding the
brain and spinal cord.
 It can be life-threatening because of the inflammation’s proximity to the brain
and spinal cord; therefore the condition is classified as a medical emergency.
 If not treated, meningitis can lead to brain swelling and cause permanent
disability, coma, and even death.
 Broadly classified as :
I. Acute meningitis
II. Chronic meningitis
WHAT IS MENINGITIS?
TERMS
Set of symptoms similar to those of meningitis but not caused by meningitis.
 Meningism is caused by non-meningitic irritation of the meninges, usually associated
with acute febrile illness, especially in children and adolescents.
 It therefore requires differentiating from other CNS problems with similar symptoms,
including meningitis and some types of intracranial hemorrhage.
 The severity of clinical features varies with the causative organism.
M E N I N G I S M
RISK FACTORS
Risk factors that place people at higher risk for bacterial meningitis include
the following:
 Adults older than 60 years of age
 Children younger than 5 years of age
 People with alcoholism
 People with sickle cell anemia
 People with cancer, especially those receiving chemotherapy
 People who have received transplants and are taking drugs that suppress
the immune system
 People with diabetes
 Those recently exposed to meningitis at home
 People living in close quarters (military barracks, dormitories)
 IV drug users
 People with shunts in place for hydrocephalus
ANATOMY OF MENINGES
The meninges is the system of the membranes which envelops
the CNS. It has 3 layers:
1. Dura mater
2. Arachnoid mater
3. Pia mater
Subarachnoid space – is the space which is filled with CSF
ANATOMY OF MENINGES
ANATOMY OF MENINGES
ANATOMY OF MENINGES
TRANSMISSION
H O W D O E S M E N I N G I T I S S P R E A D ?
An infectious agent can gain access to the CNS and cause meningeal disease via any of
the 3 following major pathways:
Direct contiguous spread (e.g. sinusitis, otitis media, congenital malformations, trauma,
or direct inoculation during intracranial manipulation)
1 . I N V A S I O N O F T H E B L O O D S T R E A M
Invasion of the bloodstream (i.e., bacteremia, viremia, fungemia, or parasitemia) and
subsequent hematogenous seeding of the CNS
2 . R E T R O G R A D E N E U R O N A L PAT H W AY
A retrograde neuronal (eg, olfactory and peripheral nerves) pathway (eg, Naegleria
fowleri or Gnathostoma spinigerum)
3 . D I R E C T C O N T I G U O U S S P R E A D
TRANSMISSION
H O W D O E S M E N I N G I T I S S P R E A D ?
3 . D I R E C T C O N T I G U O U S S P R E A D
 Local extension from contiguous extracerebral infection (eg, otitis media,
mastoiditis, or sinusitis) is a common cause.
 Possible pathways for the migration of pathogens from the middle ear to the
meninges include the following:
1. The bloodstream
2. Preformed tissue planes (eg, posterior fossa)
3. Temporal bone fractures
4. The oval or round window membranes of the labyrinths
PATHOGENESIS
PATHOGENESIS
PROGNOSIS
Patients with meningitis who present with an impaired level of
consciousness are at increased risk for neurologic sequelae or death.
A seizure during an episode of meningitis also is a risk factor for mortality
or neurologic sequelae, particularly if the seizure is prolonged or difficult
to control.
In bacterial meningitis, several risk factors are associated with death and
with neurologic disability. A risk score has been derived and validated in
adults with bacterial meningitis. This score includes the following
variables, which are associated with an adverse clinical outcome:
1. Older age
2. Increased heart rate
3. Lower Glasgow Coma Scale score
4. Cranial nerve palsies
5. CSF leukocyte count lower than 1000/μL
6. Gram-positive cocci on CSF Gram stain
PROGNOSIS
 Advanced bacterial meningitis can lead to brain damage,
coma, and death.
 In 50% of patients, several complications may develop in the
days to weeks following infection.
 Long-term sequelae are seen in as many as 30% of survivors
and vary with etiologic agent, patient age, presenting
features, and hospital course. Patients usually have subtle CNS
changes.
AETIOLOGY
B A C T E R I A L
V I R A L
F U N G A L
P H Y S I C A L I N J U R Y
D R U G S R E A C T I O N
Severity/ treatment of illness differ depending on the cause. Thus, it is
important to know the specific cause of meningitis.
AETIOLOGY
B A C T E R I A L M E N I N G I T I S V I R A L M E N I N G I T I S
 The most serious form of meningitis is
bacterial.
 Even with treatment, bacterial meningitis
can be fatal some of the time.
 If bacterial meningitis progresses rapidly,
in 24 hours or less, death may occur in
more than half of those who develop it,
even with proper medical treatment.
 Determining how many people get viral
meningitis is difficult because it often
remains undiagnosed and is easily
confused with the flu.
 The prognosis for viral meningitis is much
better than that for bacterial meningitis,
with most people recovering completely
with simple treatment of the symptoms.
AETIOLOGY
F U N G A L M E N I N G I T I S A S E P T I C M E N I N G I T I S
 Fungal meningitis is a serious form of
meningitis that is normally limited to
people with impaired immune systems.
 Aseptic meningitis is a term referring to
the broad category of meningitis that is
not caused by bacteria.
 Approximately 50% of aseptic meningitis
is due to viral infections.
 Other less common causes include drug
reactions or allergies, and inflammatory
diseases like lupus.
 It occurs in individuals of all ages but is
more common in children
BACTERIAL CAUSES
 Listeria monocytogenes ( >50 years old)
 Group A β-hemolytic streptococcus
 Group B β-hemolytic streptococcus
 Mycoplasma pneumoniae
 Gram –ve rods
C O M M O N O R G A N I S M S :
1. Streptococcus pneumoniae (α-hemolytic streptococcus)
2. Neisseria meningitidis
3. Haemophilus influenzae
O T H E R O R G A N I S M S :
V I R A L C A U S E S
 Enteroviruses
 Herpes simplex virus
ORGANISMS
R I S K O R P R E D I S P O S I N G F A C T O R S B A C T E R I A L P A T H O G E N
Age 3 months – 18 years
 Neisseria meningitidis
 Streptococcus penumoniae
 Haemophilus influenza
Age 18 – 50 years
 Streptococcus penumoniae
 Neisseria meningitidis
 Haemophilus influenza
Age > 50 years
 Streptococcus penumoniae
 Neisseria meningitidis
 Listeria monocytogenes
 Aerobic gram-negative bacilli
Immunocompromised state
 Streptococcus penumoniae
 Neisseria meningitidis
 Listeria monocytogenes
 Aerobic gram-negative bacilli
Intracranial manipulation, including neurosurgery
 Staphylococcus aureus
 Coagulase negative staphylococci
 Aerobic gram-negative bacilli, including
Pseudomonas aeruginosa
Basilar skull fracture
 Streptococcus penumoniae
 Haemophilus influenza
 Group A streptococci
NEISSERIA MENINGITIDIS
 Also known as meningococcal meningitis
 Gram negative aerobic cocci, capsule
 10% of healthy people are healthy nasopharyngeal
carriers
 Begin as throat infection, rash
 Vaccination is recommended
NEISSERIA MENINGITIDISSTREPTOCOCCUS PNEUMONIAE
 Gram positive diplococci
 70% of people are healthy nasopharyngeal carriers
 Most common in children (1 month to 4 years)
 Mortality: 30% in children, 80% in elderly
 Prevented by vaccination
NEISSERIA MENINGITIDISHISTORY TAKING
 ~25% of those who develop meningitis have symptoms that develop
over 24 hours. The remainder generally become ill over one to seven
days.
 ~25% of patients have concomitant sinusitis or otitis that could
predispose to S pneumoniae meningitis.
 Occasionally, if someone has been on antibiotics for another infection,
the symptoms can take longer to develop or may be less intense.
 If someone is developing fungal meningitis (most commonly someone
who is HIV positive), the symptoms may take weeks to develop.
D U R AT I O N
NEISSERIA MENINGITIDISHISTORY TAKING
 In contrast, patients with subacute bacterial meningitis and most
patients with viral meningitis present with neurologic symptoms
developing over 1 – 7 days.
 Chronic symptoms lasting longer than 1 week suggest the presence of
meningitis caused by certain viruses or by tuberculosis, syphilis, fungi
(especially cryptococci), or carcinomatosis.
D U R AT I O N
NEISSERIA MENINGITIDISHISTORY TAKING
NEISSERIA MENINGITIDISHISTORY TAKING
S Y M P T O M S I G N M E C H A N I S M
Chills, rigors Fever (T>38°) Endogenous cytokines (released during the
immune response to the invading
pathogens) affect the thermoregulatory
neurons of the hypothalamus, changing the
central regulation of body temperature.
Invading viruses or bacteria produce
exogenous substances (pyrogens) that can
also re-set the hypothalamic thermal set
point.
Nuchal rigidity (neck stiffness) Brudzinski sign and Kernig sign Flexion of the spine leads to stretching of
the meninges.
In meningitis, traction on the inflamed
meninges is painful, resulting in limited
range of motion through the spine
(especially in the cervical spine).
Altered mental status Decreased Glasgow Coma Scale (GCS) ↑ ICP → brain herniation → damage to
the reticular formation (structure in the
brainstem that governs consciousness)
NEISSERIA MENINGITIDISHISTORY TAKING
S Y M P T O M S I G N M E C H A N I S M
Focal neurological deficits, e.g. vision loss Examples: cranial nerve palsies,
hemiparesis, hypertonia, nystagmus
Cytotoxic edema and ↑ ICP lead to
neuronal damage.
Signs or symptoms depend on the affected
area (cerebrum, cerebellum, brainstem,
etc.)
Seizures Inflammation in the brain alters membrane
permeability, lowering the seizure
threshold. Exact seizure pathophysiology is
unknown.
Headache Jolt accentuation of headache: headache
worse when patient vigorously shakes head
Bacterial exotoxins, cytokines, and ↑ ICP
stimulate nociceptors in the meninges
(cerebral tissue itself lacks nerve endings
that generate pain sensation).
Photophobia Due to meningeal irritation. Mechanisms
unclear; pathways are thought to involve
the trigeminal nerve.
Nausea and vomiting ↑ ICP stimulates the area
postrema (vomiting centre), causing nausea
and vomiting.
Petechial rash Meningococcemia (due to N. meningitidis)
NEISSERIA MENINGITIDISHISTORY TAKING
O T H E R I M P O R TA N T H I S T O R Y
 Contact with TB patient (TB meningitis)
 Infection of middle ear, sinuses, lung or tooth and gum (brain abscess)
 Contact with infected bodily secretions (meningitis, herpes encephalitis)
 Sexual contact with a person infected with HIV (HIV encephalopathy)
 Penetrating head trauma (brain abscess)
 Neurosurgical complications (meningitis, brain abscess)
 A chronic illness, such as cancer
 A weakened immune system, such those with alcoholism, diabetes, HIV or people
who have had organ transplant.
 A history of recent antibiotic use should be elicited. 40% of patients who present
with acute or subacute bacterial meningitis have previously been treated with oral
antibiotics (presumably because of misdiagnosis at the time of initial presentation).
NEISSERIA MENINGITIDISPHYSICAL EXAMINATION
G E N E R A L E X A M I N AT I O N
 Non-toxic looking might suggestive of viral origin.
 Sick, toxic looking might suggest bacterial origin.
 Glasgow-coma scale
 Kernig’s sign
 Brudzinki’s sign
 Look for other source of infections:
 Cutaneous petachie/purpura rash  meningococcus
 Middle ear, sinus infection
 Pneumonia  pneumococcus
 Papilledema (increase ICP)
 Cranial nerves examination (III, IV, V, VI, and VII)
S P E C I F I C E X A M I N AT I O N
NEISSERIA MENINGITIDISPHYSICAL EXAMINATION
K E R N I G ’ S S I G N ( M E N I N G E A L S T R E T C H T E S T )
NEISSERIA MENINGITIDISPHYSICAL EXAMINATION
B R U D Z I N S K I ’ S S I G N ( M E N I N G E A L S T R E T C H T E S T )
NEISSERIA MENINGITIDISCLINICAL FEATURES
C H R O N I C M E N I N G I T I S
 Lymphadenopathy
 Papilledema and tuberculomas during funduscopy
 Meningismus
 Cranial nerve palsies
 Occurs most common shortly after primary infection in childhood or as part of
military TB.
 The presentation of chronic tuberculous meningitis may be acute, but the classic
presentation is subacute and spans weeks. Patients generally have a prodrome
consisting of fever of varying degrees, malaise, and intermittent headaches.
T U B E R C U L O U S M E N I N G I T I S
NEISSERIA MENINGITIDISCLINICAL FEATURES
Cranial nerve palsies (III, IV, V, VI, and VII) often develop, suggesting basilar
meningeal involvement.
Clinical staging of tuberculous meningitis is based on neurologic status, as
follows:
 Stage 1 - No change in mental function, with no deficits and no
hydrocephalus
 Stage 2 - Confusion and evidence of neurologic deficit
 Stage 3 - Stupor and lethargy
T U B E R C U L O U S M E N I N G I T I S
C L I N I C A L S TA G I N G O F T U B E R C U L O U S M E N I N G I T I S
NEISSERIA MENINGITIDISCLINICAL FEATURES
NEISSERIA MENINGITIDISCOMPLICATIONS
1 . H E A R I N G L O S S
2 . C E R E B R A L O E D E M A A N D I N C R E A S E D I C P
4 . B R A I N A B S C E S S
4 . S T R O K E
Infections / inflammation from subarachnoid space  via cochlear aqueduct  inner ear
 Inflammatory response – damages cochlear (hair cells)
Cerebral edema may be vasogenic, from increased vascular permeability, cytotoxic from cerebral hypoxia, interstitial, from
increased CSF volume, or a combination of all. Increased intracranial pressure, in turn, causes decreased cerebral perfusion,
hypoxia/ischemia, and neuronal necrosis.
3 . D I S S E M I N AT E D I N T R A V A S C U L A R C O A G U L O PAT H Y ( D I C )
Bacterial products can damage the brain and blood vessels directly. Bacterial toxins cause neuronal apoptosis, and cell wall
lipopolysaccharide (endotoxin), released from bacteria, activates clotting causing disseminated intravascular coagulation (DIC).
NEISSERIA MENINGITIDISDIFFERENTIAL DIAGNOSIS
1 . S u b a r a c h n o i d h e m o r r h a g e
2 . T B m e n i n g i t i s
3 . S p a c e - o c c u p y i n g l e s i o n
4 . M e n i n g o e n c a p h a l i t i s
5 . E p i l e p s y
NEISSERIA MENINGITIDISINVESTIGATIONS
B L O O D T E S T S
1. Full blood count ( white cell count)
2. C-reactive protein
3. Blood culture and sensitivity
L U M B A R P U N C T U R E A N D C S F A N A LY S I S
For definitive diagnosis of meningitis, CSF needs to be collected for analysis.
C O N T R A I N D I C AT I O N S
 Infected skin over needle entry site
 Suspicion of increase ICP
 Coagulopathy
 Significant cardiorespiratory compromise
 Immunocompromised
NEISSERIA MENINGITIDISINVESTIGATIONS
L U M B A R P U N C T U R E A N D C S F A N A LY S I S
T E S T B A C T E R I A L V I R A L F U N G A L T U B E R C U L A R
Opening pressure Elevated Normal Variable Variable
WBC count >1,000 / mm3 <100/mm3 Variable Variable
Cell differential Neutrophils Lymphocytes Lymphocytes Lymphocytes
Protein Mild to marked
elevation
Normal or mildly
elevated
Elevated Very high
CSF-to-serum
glucose ratio
Markedly decreased normal Low Low
I M A G I N G
If a patient has the following:
Focal neurologic findings (excluding cranial nerve palsies), new-onset seizures, severely immunocompromised
state, papilledema or presents with coma, perform a head computed tomography scan prior to doing a lumbar
puncture to rule out the presence of intracranial mass lesions because of the potential risk for herniation
NEISSERIA MENINGITIDISMANAGEMENT
S U P P O R T I V E T R E AT M E N T
Airway, breathing and circulation
 Mechanical ventilation – level of consciousness is very low / evidence of respiratory failure
 Intravenous fluid therapy – if hypotension or shock are present
Monitor vital signs and neurologic status regularly
Maintain adequate hydration and nutrition – tube feeding may be necessary
D E F I N I T I V E T R E AT M E N T ( P H A R M A C O T H E R PA P Y )
1. Antibiotic therapy
2. Anti-inflammatory therapy
3. Agents to decrease intracranial pressure (ICP)
4. Anti-convulsants
NEISSERIA MENINGITIDISMANAGEMENT
A N T I B I O T I C S ( A C U T E M E N I N G I T I S )
I N F E C T I O N
S U G G E S T E D T R E A T M E N T
C O M M E N T S
P R E F E R R E D A L T E R N A T I V E
Common organisms:
 Streptococcus
pneumoniae
 Neisseria meningitidis
 Haemophilus influenzae
Ceftriaxone 2gm IV q12h
OR
Cefotaxime 2 – 4gm IV q8h
Dexamethasone 10mg IV q6h
is recommended to be
administered 15 to 20 minutes
before or at the time of first
dose of antibiotics, for up to 4
days or until there is no
evidence of pneumococcal
meningitis.
Antibiotic treatment must be
started immediately,
regardless of any
investigations undertaken. If
no organism isolated and
patient is responding,
continue antibiotics for 14
days.
NEISSERIA MENINGITIDISMANAGEMENT
A N T I B I O T I C S ( A C U T E M E N I N G I T I S )
I S O L A T E D C A U S A T I V E
O R G A N I S M
S U G G E S T E D T R E A T M E N T
C O M M E N T S
P R E F E R R E D A L T E R N A T I V E
HAEMOPHILUS INFUENZAE
(GRAM –VE BACILLI)
Ceftriaxone 2gm IV q12h
STREPTOCOCCUS PNEUMONIAE
(GRAM +VE COCCI)
Benzylpenicillin 4MU IV q4-
6h for 10-14 days.
For penicillin resistant strains
Vancomycin 1gm IV q12h
NEISSERIA MENINGITIDIS
(GRAM –VE COCCI)
Prophylaxis for household and
close contact of meningococcal
meningitis
Ceftriaxone 2gm IV q12h
Ciprofloxacin 500mg PO as
single dose;
Close contacts are defined as
those individuals who have
had contact with
oropharyngeal secretions
either through kissing or by
sharing toys, beverages, or
cigarettes.
NEISSERIA MENINGITIDISMANAGEMENT
A N T I B I O T I C S ( C H R O N I C M E N I N G I T I S )
I N F E C T I O N
S U G G E S T E D T R E A T M E N T
C O M M E N T S
P R E F E R R E D A L T E R N A T I V E
TUBERCULOUS MENINGITIS
Mycobacterium tuberculosis
Intensive 2 months S/EHRZ
and 10 months HR
Pyridoxine 10- 50mg PO q24h
needs to be prescribed
together with Isoniazid.
(Streptomycin should replace
Ethambutol in TB meningitis
as it crosses BBB better than
Ethambutol.)
Treatment is continued for 12
months.
CPG on management of
Tuberculosis, 3rd edition,
2012; 16, 22, 40-42, 56)
WHO Treatment of
Tuberculosis Guidelines, 4th
ed. 2009
NEISSERIA MENINGITIDISMANAGEMENT
A N T I - I N F L A M M AT O R Y T H E R A P Y
Dexamethasone 10 mg IV 6 hourly x 4 days
Mannitol 1 – 1.5 g/kg IV given over 15 minutes
I C P L O W E R I N G A G E N T
A N T I C O N V U L S A N T S
Diazepam, Lorazepam
Administered if patient has seizure
Action:
Mannitol is a hyperosmolar agent that makes the intravascular space hyperosmolar to the brain and permits movement of water
from brain tissue into the intravascular compartment
NEISSERIA MENINGITIDISPREVENTION AND PROPHYLAXIS
P R E C A U T I O N
Completion of recommended schedule of vaccination is an effective way of protecting individuals from certain
types of bacterial meningitis (E.g. meningococcus, pneumococcus and Hib)
F O L L O W U P
 Repeat cerebrospinal fluid exam in patients in whom there is doubt about the success of therapy or the
accuracy of the initial diagnosis
 Patients who respond promptly to therapy may no longer need repeat cerebrospinal fluid exams
 Monitor for hydrocephalus and treat the condition appropriately - hydrocephalus usually manifests within the
first few weeks of infection and is treated with ventriculoperitoneal shunting
 Monitor for neurologic sequelae and provide appropriate supportive therapy
 Sequelae include hearing impairment, cranial nerve palsies and motor deficits
 Supportive therapy should be individually tailored
Use of mask, gloves, and gowns prevents spread of disease as meningitis is a droplet infection
V A C C I N AT I O N
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Headache types & management
Headache types & managementHeadache types & management
Headache types & management
 
multiple sclerosis
multiple sclerosismultiple sclerosis
multiple sclerosis
 
Guillain Barre Syndrome
Guillain Barre SyndromeGuillain Barre Syndrome
Guillain Barre Syndrome
 
Brain abscess
Brain abscessBrain abscess
Brain abscess
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Myasthenia Gravis
Myasthenia GravisMyasthenia Gravis
Myasthenia Gravis
 
Encephalitis
EncephalitisEncephalitis
Encephalitis
 
Cerebrovascular accident
Cerebrovascular accidentCerebrovascular accident
Cerebrovascular accident
 
Meningitis
MeningitisMeningitis
Meningitis
 
Encephalitis
EncephalitisEncephalitis
Encephalitis
 
Tuberculous meningitis
Tuberculous meningitisTuberculous meningitis
Tuberculous meningitis
 
Peripheral Neuropathy
Peripheral NeuropathyPeripheral Neuropathy
Peripheral Neuropathy
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis In Children
Meningitis  In ChildrenMeningitis  In Children
Meningitis In Children
 
Migrane ppt
Migrane pptMigrane ppt
Migrane ppt
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
Seizures
SeizuresSeizures
Seizures
 
Meningitis and its management
Meningitis and its managementMeningitis and its management
Meningitis and its management
 

Ähnlich wie Management of Meningitis

22 Purulent Meningitis
22 Purulent Meningitis22 Purulent Meningitis
22 Purulent Meningitisghalan
 
Cns infections Lecture
Cns infections LectureCns infections Lecture
Cns infections Lecturetest
 
2. Meningitis diseses of the brain membrane.pptx
2. Meningitis  diseses of the brain membrane.pptx2. Meningitis  diseses of the brain membrane.pptx
2. Meningitis diseses of the brain membrane.pptxabdinuh1997
 
Lecture 11. meningitis
Lecture 11. meningitisLecture 11. meningitis
Lecture 11. meningitisVasyl Sorokhan
 
Cns infections
Cns infectionsCns infections
Cns infectionsLetaJarso
 
BACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxBACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxHajaSovula2
 
CNS Infections Siddiqui
CNS Infections SiddiquiCNS Infections Siddiqui
CNS Infections Siddiquitjsiddiqui
 
Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...WAidid
 

Ähnlich wie Management of Meningitis (20)

22 Purulent Meningitis
22 Purulent Meningitis22 Purulent Meningitis
22 Purulent Meningitis
 
Cns infections Lecture
Cns infections LectureCns infections Lecture
Cns infections Lecture
 
2. Meningitis diseses of the brain membrane.pptx
2. Meningitis  diseses of the brain membrane.pptx2. Meningitis  diseses of the brain membrane.pptx
2. Meningitis diseses of the brain membrane.pptx
 
Meningitis
Meningitis Meningitis
Meningitis
 
MENINGITIS.ppt
MENINGITIS.pptMENINGITIS.ppt
MENINGITIS.ppt
 
Lecture 11. meningitis
Lecture 11. meningitisLecture 11. meningitis
Lecture 11. meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
Bacterial meningitis
Bacterial meningitis Bacterial meningitis
Bacterial meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
GROUP NO 1 PPT.pptx
GROUP NO 1 PPT.pptxGROUP NO 1 PPT.pptx
GROUP NO 1 PPT.pptx
 
Meningitis 2012
Meningitis 2012Meningitis 2012
Meningitis 2012
 
CNS infections
CNS infectionsCNS infections
CNS infections
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptx
 
Cns infections
Cns infectionsCns infections
Cns infections
 
BACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxBACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptx
 
Essay On Unit 9
Essay On Unit 9Essay On Unit 9
Essay On Unit 9
 
Pyogenic infection
Pyogenic infectionPyogenic infection
Pyogenic infection
 
CNS Infections Siddiqui
CNS Infections SiddiquiCNS Infections Siddiqui
CNS Infections Siddiqui
 
Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...
 
#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis
 

Mehr von yuyuricci

Management of intestinal obstruction
Management of intestinal obstructionManagement of intestinal obstruction
Management of intestinal obstructionyuyuricci
 
Management of Parathyroid disoders
Management of Parathyroid disodersManagement of Parathyroid disoders
Management of Parathyroid disodersyuyuricci
 
Inguinalscrotal Disease
Inguinalscrotal DiseaseInguinalscrotal Disease
Inguinalscrotal Diseaseyuyuricci
 
Pre and Post operative in Paediatric Surgery
Pre and Post operative in Paediatric SurgeryPre and Post operative in Paediatric Surgery
Pre and Post operative in Paediatric Surgeryyuyuricci
 
Post Operative Care & Complication
Post Operative Care  & ComplicationPost Operative Care  & Complication
Post Operative Care & Complicationyuyuricci
 
Adrenal Neoplasia and MEN Syndrome
Adrenal Neoplasia and MEN SyndromeAdrenal Neoplasia and MEN Syndrome
Adrenal Neoplasia and MEN Syndromeyuyuricci
 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemiayuyuricci
 
Management of Thyroid Diseases & Emergencies
Management of Thyroid Diseases & EmergenciesManagement of Thyroid Diseases & Emergencies
Management of Thyroid Diseases & Emergenciesyuyuricci
 
Management of Respiratory Failure
Management of Respiratory FailureManagement of Respiratory Failure
Management of Respiratory Failureyuyuricci
 
Management of Thalassemia
Management of ThalassemiaManagement of Thalassemia
Management of Thalassemiayuyuricci
 
Hypertension
HypertensionHypertension
Hypertensionyuyuricci
 
Management of Bronchial Asthma
Management of Bronchial AsthmaManagement of Bronchial Asthma
Management of Bronchial Asthmayuyuricci
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Diseaseyuyuricci
 
Urinary Tract Infections
Urinary Tract InfectionsUrinary Tract Infections
Urinary Tract Infectionsyuyuricci
 
Arrhythmia Recognition & Management
Arrhythmia Recognition & ManagementArrhythmia Recognition & Management
Arrhythmia Recognition & Managementyuyuricci
 
Peripheral Nerve Injuries
Peripheral Nerve InjuriesPeripheral Nerve Injuries
Peripheral Nerve Injuriesyuyuricci
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritisyuyuricci
 
Septic Arthritis
Septic ArthritisSeptic Arthritis
Septic Arthritisyuyuricci
 
Acute Osteomyelitis
Acute OsteomyelitisAcute Osteomyelitis
Acute Osteomyelitisyuyuricci
 
Compartment syndrome
Compartment syndromeCompartment syndrome
Compartment syndromeyuyuricci
 

Mehr von yuyuricci (20)

Management of intestinal obstruction
Management of intestinal obstructionManagement of intestinal obstruction
Management of intestinal obstruction
 
Management of Parathyroid disoders
Management of Parathyroid disodersManagement of Parathyroid disoders
Management of Parathyroid disoders
 
Inguinalscrotal Disease
Inguinalscrotal DiseaseInguinalscrotal Disease
Inguinalscrotal Disease
 
Pre and Post operative in Paediatric Surgery
Pre and Post operative in Paediatric SurgeryPre and Post operative in Paediatric Surgery
Pre and Post operative in Paediatric Surgery
 
Post Operative Care & Complication
Post Operative Care  & ComplicationPost Operative Care  & Complication
Post Operative Care & Complication
 
Adrenal Neoplasia and MEN Syndrome
Adrenal Neoplasia and MEN SyndromeAdrenal Neoplasia and MEN Syndrome
Adrenal Neoplasia and MEN Syndrome
 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemia
 
Management of Thyroid Diseases & Emergencies
Management of Thyroid Diseases & EmergenciesManagement of Thyroid Diseases & Emergencies
Management of Thyroid Diseases & Emergencies
 
Management of Respiratory Failure
Management of Respiratory FailureManagement of Respiratory Failure
Management of Respiratory Failure
 
Management of Thalassemia
Management of ThalassemiaManagement of Thalassemia
Management of Thalassemia
 
Hypertension
HypertensionHypertension
Hypertension
 
Management of Bronchial Asthma
Management of Bronchial AsthmaManagement of Bronchial Asthma
Management of Bronchial Asthma
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
 
Urinary Tract Infections
Urinary Tract InfectionsUrinary Tract Infections
Urinary Tract Infections
 
Arrhythmia Recognition & Management
Arrhythmia Recognition & ManagementArrhythmia Recognition & Management
Arrhythmia Recognition & Management
 
Peripheral Nerve Injuries
Peripheral Nerve InjuriesPeripheral Nerve Injuries
Peripheral Nerve Injuries
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Septic Arthritis
Septic ArthritisSeptic Arthritis
Septic Arthritis
 
Acute Osteomyelitis
Acute OsteomyelitisAcute Osteomyelitis
Acute Osteomyelitis
 
Compartment syndrome
Compartment syndromeCompartment syndrome
Compartment syndrome
 

Kürzlich hochgeladen

SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 

Kürzlich hochgeladen (20)

SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 

Management of Meningitis

  • 1. M E N I N G I T I S P R E S E N T E D B Y N U R U L H I D A Y U B I N T I I B R A H I M N I K N O R L I Y A N A
  • 2. OUTLINE 1. Introduction to meningitis 2. Risk factor 3. Anatomy and prognosis 4. Aetiology 5. History and physical examination 6. Clinical features 7. Complications 8. Differential diagnosis 9. Investigations 10. Management
  • 3. INTRODUCTION  Meningitis is a disease caused by the inflammation of the meninges.  The inflammation is usually caused by an infection of the fluid surrounding the brain and spinal cord.  It can be life-threatening because of the inflammation’s proximity to the brain and spinal cord; therefore the condition is classified as a medical emergency.  If not treated, meningitis can lead to brain swelling and cause permanent disability, coma, and even death.  Broadly classified as : I. Acute meningitis II. Chronic meningitis WHAT IS MENINGITIS?
  • 4. TERMS Set of symptoms similar to those of meningitis but not caused by meningitis.  Meningism is caused by non-meningitic irritation of the meninges, usually associated with acute febrile illness, especially in children and adolescents.  It therefore requires differentiating from other CNS problems with similar symptoms, including meningitis and some types of intracranial hemorrhage.  The severity of clinical features varies with the causative organism. M E N I N G I S M
  • 5. RISK FACTORS Risk factors that place people at higher risk for bacterial meningitis include the following:  Adults older than 60 years of age  Children younger than 5 years of age  People with alcoholism  People with sickle cell anemia  People with cancer, especially those receiving chemotherapy  People who have received transplants and are taking drugs that suppress the immune system  People with diabetes  Those recently exposed to meningitis at home  People living in close quarters (military barracks, dormitories)  IV drug users  People with shunts in place for hydrocephalus
  • 6. ANATOMY OF MENINGES The meninges is the system of the membranes which envelops the CNS. It has 3 layers: 1. Dura mater 2. Arachnoid mater 3. Pia mater Subarachnoid space – is the space which is filled with CSF
  • 10. TRANSMISSION H O W D O E S M E N I N G I T I S S P R E A D ? An infectious agent can gain access to the CNS and cause meningeal disease via any of the 3 following major pathways: Direct contiguous spread (e.g. sinusitis, otitis media, congenital malformations, trauma, or direct inoculation during intracranial manipulation) 1 . I N V A S I O N O F T H E B L O O D S T R E A M Invasion of the bloodstream (i.e., bacteremia, viremia, fungemia, or parasitemia) and subsequent hematogenous seeding of the CNS 2 . R E T R O G R A D E N E U R O N A L PAT H W AY A retrograde neuronal (eg, olfactory and peripheral nerves) pathway (eg, Naegleria fowleri or Gnathostoma spinigerum) 3 . D I R E C T C O N T I G U O U S S P R E A D
  • 11. TRANSMISSION H O W D O E S M E N I N G I T I S S P R E A D ? 3 . D I R E C T C O N T I G U O U S S P R E A D  Local extension from contiguous extracerebral infection (eg, otitis media, mastoiditis, or sinusitis) is a common cause.  Possible pathways for the migration of pathogens from the middle ear to the meninges include the following: 1. The bloodstream 2. Preformed tissue planes (eg, posterior fossa) 3. Temporal bone fractures 4. The oval or round window membranes of the labyrinths
  • 14. PROGNOSIS Patients with meningitis who present with an impaired level of consciousness are at increased risk for neurologic sequelae or death. A seizure during an episode of meningitis also is a risk factor for mortality or neurologic sequelae, particularly if the seizure is prolonged or difficult to control. In bacterial meningitis, several risk factors are associated with death and with neurologic disability. A risk score has been derived and validated in adults with bacterial meningitis. This score includes the following variables, which are associated with an adverse clinical outcome: 1. Older age 2. Increased heart rate 3. Lower Glasgow Coma Scale score 4. Cranial nerve palsies 5. CSF leukocyte count lower than 1000/μL 6. Gram-positive cocci on CSF Gram stain
  • 15. PROGNOSIS  Advanced bacterial meningitis can lead to brain damage, coma, and death.  In 50% of patients, several complications may develop in the days to weeks following infection.  Long-term sequelae are seen in as many as 30% of survivors and vary with etiologic agent, patient age, presenting features, and hospital course. Patients usually have subtle CNS changes.
  • 16. AETIOLOGY B A C T E R I A L V I R A L F U N G A L P H Y S I C A L I N J U R Y D R U G S R E A C T I O N Severity/ treatment of illness differ depending on the cause. Thus, it is important to know the specific cause of meningitis.
  • 17. AETIOLOGY B A C T E R I A L M E N I N G I T I S V I R A L M E N I N G I T I S  The most serious form of meningitis is bacterial.  Even with treatment, bacterial meningitis can be fatal some of the time.  If bacterial meningitis progresses rapidly, in 24 hours or less, death may occur in more than half of those who develop it, even with proper medical treatment.  Determining how many people get viral meningitis is difficult because it often remains undiagnosed and is easily confused with the flu.  The prognosis for viral meningitis is much better than that for bacterial meningitis, with most people recovering completely with simple treatment of the symptoms.
  • 18. AETIOLOGY F U N G A L M E N I N G I T I S A S E P T I C M E N I N G I T I S  Fungal meningitis is a serious form of meningitis that is normally limited to people with impaired immune systems.  Aseptic meningitis is a term referring to the broad category of meningitis that is not caused by bacteria.  Approximately 50% of aseptic meningitis is due to viral infections.  Other less common causes include drug reactions or allergies, and inflammatory diseases like lupus.  It occurs in individuals of all ages but is more common in children
  • 19. BACTERIAL CAUSES  Listeria monocytogenes ( >50 years old)  Group A β-hemolytic streptococcus  Group B β-hemolytic streptococcus  Mycoplasma pneumoniae  Gram –ve rods C O M M O N O R G A N I S M S : 1. Streptococcus pneumoniae (α-hemolytic streptococcus) 2. Neisseria meningitidis 3. Haemophilus influenzae O T H E R O R G A N I S M S : V I R A L C A U S E S  Enteroviruses  Herpes simplex virus
  • 20. ORGANISMS R I S K O R P R E D I S P O S I N G F A C T O R S B A C T E R I A L P A T H O G E N Age 3 months – 18 years  Neisseria meningitidis  Streptococcus penumoniae  Haemophilus influenza Age 18 – 50 years  Streptococcus penumoniae  Neisseria meningitidis  Haemophilus influenza Age > 50 years  Streptococcus penumoniae  Neisseria meningitidis  Listeria monocytogenes  Aerobic gram-negative bacilli Immunocompromised state  Streptococcus penumoniae  Neisseria meningitidis  Listeria monocytogenes  Aerobic gram-negative bacilli Intracranial manipulation, including neurosurgery  Staphylococcus aureus  Coagulase negative staphylococci  Aerobic gram-negative bacilli, including Pseudomonas aeruginosa Basilar skull fracture  Streptococcus penumoniae  Haemophilus influenza  Group A streptococci
  • 21. NEISSERIA MENINGITIDIS  Also known as meningococcal meningitis  Gram negative aerobic cocci, capsule  10% of healthy people are healthy nasopharyngeal carriers  Begin as throat infection, rash  Vaccination is recommended
  • 22. NEISSERIA MENINGITIDISSTREPTOCOCCUS PNEUMONIAE  Gram positive diplococci  70% of people are healthy nasopharyngeal carriers  Most common in children (1 month to 4 years)  Mortality: 30% in children, 80% in elderly  Prevented by vaccination
  • 23. NEISSERIA MENINGITIDISHISTORY TAKING  ~25% of those who develop meningitis have symptoms that develop over 24 hours. The remainder generally become ill over one to seven days.  ~25% of patients have concomitant sinusitis or otitis that could predispose to S pneumoniae meningitis.  Occasionally, if someone has been on antibiotics for another infection, the symptoms can take longer to develop or may be less intense.  If someone is developing fungal meningitis (most commonly someone who is HIV positive), the symptoms may take weeks to develop. D U R AT I O N
  • 24. NEISSERIA MENINGITIDISHISTORY TAKING  In contrast, patients with subacute bacterial meningitis and most patients with viral meningitis present with neurologic symptoms developing over 1 – 7 days.  Chronic symptoms lasting longer than 1 week suggest the presence of meningitis caused by certain viruses or by tuberculosis, syphilis, fungi (especially cryptococci), or carcinomatosis. D U R AT I O N
  • 26. NEISSERIA MENINGITIDISHISTORY TAKING S Y M P T O M S I G N M E C H A N I S M Chills, rigors Fever (T>38°) Endogenous cytokines (released during the immune response to the invading pathogens) affect the thermoregulatory neurons of the hypothalamus, changing the central regulation of body temperature. Invading viruses or bacteria produce exogenous substances (pyrogens) that can also re-set the hypothalamic thermal set point. Nuchal rigidity (neck stiffness) Brudzinski sign and Kernig sign Flexion of the spine leads to stretching of the meninges. In meningitis, traction on the inflamed meninges is painful, resulting in limited range of motion through the spine (especially in the cervical spine). Altered mental status Decreased Glasgow Coma Scale (GCS) ↑ ICP → brain herniation → damage to the reticular formation (structure in the brainstem that governs consciousness)
  • 27. NEISSERIA MENINGITIDISHISTORY TAKING S Y M P T O M S I G N M E C H A N I S M Focal neurological deficits, e.g. vision loss Examples: cranial nerve palsies, hemiparesis, hypertonia, nystagmus Cytotoxic edema and ↑ ICP lead to neuronal damage. Signs or symptoms depend on the affected area (cerebrum, cerebellum, brainstem, etc.) Seizures Inflammation in the brain alters membrane permeability, lowering the seizure threshold. Exact seizure pathophysiology is unknown. Headache Jolt accentuation of headache: headache worse when patient vigorously shakes head Bacterial exotoxins, cytokines, and ↑ ICP stimulate nociceptors in the meninges (cerebral tissue itself lacks nerve endings that generate pain sensation). Photophobia Due to meningeal irritation. Mechanisms unclear; pathways are thought to involve the trigeminal nerve. Nausea and vomiting ↑ ICP stimulates the area postrema (vomiting centre), causing nausea and vomiting. Petechial rash Meningococcemia (due to N. meningitidis)
  • 28. NEISSERIA MENINGITIDISHISTORY TAKING O T H E R I M P O R TA N T H I S T O R Y  Contact with TB patient (TB meningitis)  Infection of middle ear, sinuses, lung or tooth and gum (brain abscess)  Contact with infected bodily secretions (meningitis, herpes encephalitis)  Sexual contact with a person infected with HIV (HIV encephalopathy)  Penetrating head trauma (brain abscess)  Neurosurgical complications (meningitis, brain abscess)  A chronic illness, such as cancer  A weakened immune system, such those with alcoholism, diabetes, HIV or people who have had organ transplant.  A history of recent antibiotic use should be elicited. 40% of patients who present with acute or subacute bacterial meningitis have previously been treated with oral antibiotics (presumably because of misdiagnosis at the time of initial presentation).
  • 29. NEISSERIA MENINGITIDISPHYSICAL EXAMINATION G E N E R A L E X A M I N AT I O N  Non-toxic looking might suggestive of viral origin.  Sick, toxic looking might suggest bacterial origin.  Glasgow-coma scale  Kernig’s sign  Brudzinki’s sign  Look for other source of infections:  Cutaneous petachie/purpura rash  meningococcus  Middle ear, sinus infection  Pneumonia  pneumococcus  Papilledema (increase ICP)  Cranial nerves examination (III, IV, V, VI, and VII) S P E C I F I C E X A M I N AT I O N
  • 30. NEISSERIA MENINGITIDISPHYSICAL EXAMINATION K E R N I G ’ S S I G N ( M E N I N G E A L S T R E T C H T E S T )
  • 31. NEISSERIA MENINGITIDISPHYSICAL EXAMINATION B R U D Z I N S K I ’ S S I G N ( M E N I N G E A L S T R E T C H T E S T )
  • 32. NEISSERIA MENINGITIDISCLINICAL FEATURES C H R O N I C M E N I N G I T I S  Lymphadenopathy  Papilledema and tuberculomas during funduscopy  Meningismus  Cranial nerve palsies  Occurs most common shortly after primary infection in childhood or as part of military TB.  The presentation of chronic tuberculous meningitis may be acute, but the classic presentation is subacute and spans weeks. Patients generally have a prodrome consisting of fever of varying degrees, malaise, and intermittent headaches. T U B E R C U L O U S M E N I N G I T I S
  • 33. NEISSERIA MENINGITIDISCLINICAL FEATURES Cranial nerve palsies (III, IV, V, VI, and VII) often develop, suggesting basilar meningeal involvement. Clinical staging of tuberculous meningitis is based on neurologic status, as follows:  Stage 1 - No change in mental function, with no deficits and no hydrocephalus  Stage 2 - Confusion and evidence of neurologic deficit  Stage 3 - Stupor and lethargy T U B E R C U L O U S M E N I N G I T I S C L I N I C A L S TA G I N G O F T U B E R C U L O U S M E N I N G I T I S
  • 35. NEISSERIA MENINGITIDISCOMPLICATIONS 1 . H E A R I N G L O S S 2 . C E R E B R A L O E D E M A A N D I N C R E A S E D I C P 4 . B R A I N A B S C E S S 4 . S T R O K E Infections / inflammation from subarachnoid space  via cochlear aqueduct  inner ear  Inflammatory response – damages cochlear (hair cells) Cerebral edema may be vasogenic, from increased vascular permeability, cytotoxic from cerebral hypoxia, interstitial, from increased CSF volume, or a combination of all. Increased intracranial pressure, in turn, causes decreased cerebral perfusion, hypoxia/ischemia, and neuronal necrosis. 3 . D I S S E M I N AT E D I N T R A V A S C U L A R C O A G U L O PAT H Y ( D I C ) Bacterial products can damage the brain and blood vessels directly. Bacterial toxins cause neuronal apoptosis, and cell wall lipopolysaccharide (endotoxin), released from bacteria, activates clotting causing disseminated intravascular coagulation (DIC).
  • 36. NEISSERIA MENINGITIDISDIFFERENTIAL DIAGNOSIS 1 . S u b a r a c h n o i d h e m o r r h a g e 2 . T B m e n i n g i t i s 3 . S p a c e - o c c u p y i n g l e s i o n 4 . M e n i n g o e n c a p h a l i t i s 5 . E p i l e p s y
  • 37. NEISSERIA MENINGITIDISINVESTIGATIONS B L O O D T E S T S 1. Full blood count ( white cell count) 2. C-reactive protein 3. Blood culture and sensitivity L U M B A R P U N C T U R E A N D C S F A N A LY S I S For definitive diagnosis of meningitis, CSF needs to be collected for analysis. C O N T R A I N D I C AT I O N S  Infected skin over needle entry site  Suspicion of increase ICP  Coagulopathy  Significant cardiorespiratory compromise  Immunocompromised
  • 38. NEISSERIA MENINGITIDISINVESTIGATIONS L U M B A R P U N C T U R E A N D C S F A N A LY S I S T E S T B A C T E R I A L V I R A L F U N G A L T U B E R C U L A R Opening pressure Elevated Normal Variable Variable WBC count >1,000 / mm3 <100/mm3 Variable Variable Cell differential Neutrophils Lymphocytes Lymphocytes Lymphocytes Protein Mild to marked elevation Normal or mildly elevated Elevated Very high CSF-to-serum glucose ratio Markedly decreased normal Low Low I M A G I N G If a patient has the following: Focal neurologic findings (excluding cranial nerve palsies), new-onset seizures, severely immunocompromised state, papilledema or presents with coma, perform a head computed tomography scan prior to doing a lumbar puncture to rule out the presence of intracranial mass lesions because of the potential risk for herniation
  • 39. NEISSERIA MENINGITIDISMANAGEMENT S U P P O R T I V E T R E AT M E N T Airway, breathing and circulation  Mechanical ventilation – level of consciousness is very low / evidence of respiratory failure  Intravenous fluid therapy – if hypotension or shock are present Monitor vital signs and neurologic status regularly Maintain adequate hydration and nutrition – tube feeding may be necessary D E F I N I T I V E T R E AT M E N T ( P H A R M A C O T H E R PA P Y ) 1. Antibiotic therapy 2. Anti-inflammatory therapy 3. Agents to decrease intracranial pressure (ICP) 4. Anti-convulsants
  • 40. NEISSERIA MENINGITIDISMANAGEMENT A N T I B I O T I C S ( A C U T E M E N I N G I T I S ) I N F E C T I O N S U G G E S T E D T R E A T M E N T C O M M E N T S P R E F E R R E D A L T E R N A T I V E Common organisms:  Streptococcus pneumoniae  Neisseria meningitidis  Haemophilus influenzae Ceftriaxone 2gm IV q12h OR Cefotaxime 2 – 4gm IV q8h Dexamethasone 10mg IV q6h is recommended to be administered 15 to 20 minutes before or at the time of first dose of antibiotics, for up to 4 days or until there is no evidence of pneumococcal meningitis. Antibiotic treatment must be started immediately, regardless of any investigations undertaken. If no organism isolated and patient is responding, continue antibiotics for 14 days.
  • 41. NEISSERIA MENINGITIDISMANAGEMENT A N T I B I O T I C S ( A C U T E M E N I N G I T I S ) I S O L A T E D C A U S A T I V E O R G A N I S M S U G G E S T E D T R E A T M E N T C O M M E N T S P R E F E R R E D A L T E R N A T I V E HAEMOPHILUS INFUENZAE (GRAM –VE BACILLI) Ceftriaxone 2gm IV q12h STREPTOCOCCUS PNEUMONIAE (GRAM +VE COCCI) Benzylpenicillin 4MU IV q4- 6h for 10-14 days. For penicillin resistant strains Vancomycin 1gm IV q12h NEISSERIA MENINGITIDIS (GRAM –VE COCCI) Prophylaxis for household and close contact of meningococcal meningitis Ceftriaxone 2gm IV q12h Ciprofloxacin 500mg PO as single dose; Close contacts are defined as those individuals who have had contact with oropharyngeal secretions either through kissing or by sharing toys, beverages, or cigarettes.
  • 42. NEISSERIA MENINGITIDISMANAGEMENT A N T I B I O T I C S ( C H R O N I C M E N I N G I T I S ) I N F E C T I O N S U G G E S T E D T R E A T M E N T C O M M E N T S P R E F E R R E D A L T E R N A T I V E TUBERCULOUS MENINGITIS Mycobacterium tuberculosis Intensive 2 months S/EHRZ and 10 months HR Pyridoxine 10- 50mg PO q24h needs to be prescribed together with Isoniazid. (Streptomycin should replace Ethambutol in TB meningitis as it crosses BBB better than Ethambutol.) Treatment is continued for 12 months. CPG on management of Tuberculosis, 3rd edition, 2012; 16, 22, 40-42, 56) WHO Treatment of Tuberculosis Guidelines, 4th ed. 2009
  • 43. NEISSERIA MENINGITIDISMANAGEMENT A N T I - I N F L A M M AT O R Y T H E R A P Y Dexamethasone 10 mg IV 6 hourly x 4 days Mannitol 1 – 1.5 g/kg IV given over 15 minutes I C P L O W E R I N G A G E N T A N T I C O N V U L S A N T S Diazepam, Lorazepam Administered if patient has seizure Action: Mannitol is a hyperosmolar agent that makes the intravascular space hyperosmolar to the brain and permits movement of water from brain tissue into the intravascular compartment
  • 44. NEISSERIA MENINGITIDISPREVENTION AND PROPHYLAXIS P R E C A U T I O N Completion of recommended schedule of vaccination is an effective way of protecting individuals from certain types of bacterial meningitis (E.g. meningococcus, pneumococcus and Hib) F O L L O W U P  Repeat cerebrospinal fluid exam in patients in whom there is doubt about the success of therapy or the accuracy of the initial diagnosis  Patients who respond promptly to therapy may no longer need repeat cerebrospinal fluid exams  Monitor for hydrocephalus and treat the condition appropriately - hydrocephalus usually manifests within the first few weeks of infection and is treated with ventriculoperitoneal shunting  Monitor for neurologic sequelae and provide appropriate supportive therapy  Sequelae include hearing impairment, cranial nerve palsies and motor deficits  Supportive therapy should be individually tailored Use of mask, gloves, and gowns prevents spread of disease as meningitis is a droplet infection V A C C I N AT I O N